Moderate to severe asthma (GINA step 3-5), followed in the outpatient clinic
Non-smokers, smokers or former smokers of ≤ 10 packets per year. For smokers, \<10 cigarettes / day and with onset asthma before onset of smoking
Obese asthma patients BMI\>30 kg / m2 FEV1 pre bronchodilator between 50 and 80% predicted
Normal Chest Xray
You may not be if
Pregnancy
Patients with a history of neoplasia, HIV + or other comorbidities that may interfere in the the study
Patients with no understanding of the study procedures or who are not able to give their free and informed consent;
Patients with other lung diseases such as chronic obstructive pulmonary disease, bronchiectasis, cystic fibrosis, or other lung diseases that may interfere with the study evaluation;
Non adherence to standard asthma treatment;
Inability to perform lung function assessment tests;
Pulmonary exacerbation up to 30 days before the first study evaluation
Clareo Health | Clinical, Inflammatory and Functional Evaluation of a Population of Severe and Obese Asthmatics: Follow up
